Infectious Disease & VaccinesJan 10, 2022By Stephanie DeMarco, PhDAnimal microbiomes hold the key to new antifungalsFrom sea squirts to ants to opossums on the side of the road, the bacteria that live in animal microbiomes are a surprising source of new antifungals.
Business & Policy NewsFeb 23, 2021By DDNews StaffA commercialization agreement for ibrexafungerpIbrexafungerp on track for FDA approval in June for vaginal yeast infections
Clinical ResearchJan 26, 2021By Mel J. YeatesIbrexafungerp advances the fight against fungusIV compound enters Phase 1, following FDA Priority Review and Fast Track designations for oral formulation